Medical News Today -
6 Jan 2014 10:00
DiamiR, LLC, a molecular diagnostics company, have announced the publication entitled "Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study" in Aging. Mild Cognitive Impairment is a condition characteristic of early stages of many neurodegenerative diseases, including Alzheimer's disease. The article can be accessed online here.
Share this Article